🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Epileptic Seizures

Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm NCT04302116NA1 site📍 Ratchathewi Kullasate Sakpichaisakul · Tests: Combination therapy with vigabatrin and prednisolone, Vigabatrin Tablets Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Seizure Prediction Using Wearable EEG NCT06978842n/a2 sites📍 Haifa📍 Ramat Gan Dux Healthcare Inc. · Tests: Wearable EEG headband for passive brain signal acquisition Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep NCT07605858n/a2 sites📍 Durham📍 Bron Hospices Civils de Lyon · Tests: Direct Electric Stimulation (DES) AI-Based Mobile Intervention on Medication Non-Adherence and Transition NCT07445074NA2 sites📍 Orlando📍 Orlando University of Central Florida · Tests: Medilepsy® Chatbot AI-Enhanced, Medilepsy® Chatbot Standard EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE NCT07253701n/a6 sites📍 Gothenburg📍 Linköping📍 Lund Karolinska Institutet Antiepileptic Drugs in Elderly Patients NCT05459597n/a1 site📍 Jinan Wei Zhao · Tests: antiepileptic drugs A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures NCT04715646Phase 336 sites📍 Hawthorne📍 Durham📍 Leuven UCB Biopharma SRL · Tests: Brivaracetam The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial NCT06924086NA1 site📍 London University College, London · Tests: Deep Brain Stimulation A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures NCT05819268NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT, CATCH-IT A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds NCT07594158Phase 31 site📍 Fukuoka Ono Pharmaceutical Co., Ltd. · Tests: Cenobamate (tablet) for 12 to < 18 year olds, Cenobamate (syrup) for 2 to < 18 year olds Study of the Link Between Structural Alterations in the Hypothalamus and Cardiac Dysautonomia in Drug-resistant Epilepsy NCT07888543NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: MRI scan, electrocardiogram A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy NCT06492720NA1 site📍 Taipei NaviFUS Corporation · Tests: Focused ultrasound (FUS) treatment Investigating Epilepsy: Screening and Evaluation NCT03478852n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures NCT06908356Phase 211 sites📍 Phoenix📍 Miami Lakes📍 Bethesda Praxis Precision Medicines · Tests: 30mg PRAX-628 Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain. NCT05459090n/a1 site📍 Pozzilli Neuromed IRCCS · Tests: ex-vivo study Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain NCT06716801n/a1 site📍 Paris Aziende Chimiche Riunite Angelini Francesco S.p.A · Tests: Cenobamate Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits NCT04419272Phase 44 sites📍 Miami📍 Boston📍 New York VA Office of Research and Development · Tests: Methylphenidate, Placebo, Methylphenidate Modulating Movement Intention Via Cortical Stimulation NCT03233399NA1 site📍 New York NYU Langone Health · Tests: Sham TMS3 stimulation, rTMS of left or right angular gyrus (AG) or frontal cortex (FC), Anodal tDCS of left or right AG… Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents NCT05126914n/a11 sites📍 Angers📍 Bordeaux📍 Brest Assistance Publique - Hôpitaux de Paris De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information NCT05140265n/a1 site📍 Albuquerque University of New Mexico Study of Transcranial Direct Current Stimulation to Treat Epilepsy NCT05673915NA1 site📍 Rochester Mayo Clinic · Tests: ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS), ActivaDose II 2.0 mA transcranial direct current s… Spatial Scene Recognition Memory in Epilepsy Surgery NCT07580183NA2 sites📍 Sacramento📍 Atlanta University of California, Davis · Tests: Virtual Tour Recognition Memory Task, Intracranial EEG Recording with Research Electrodes (Aim III only), MRI Neuroimag… Surgery as a Treatment for Medically Intractable Epilepsy NCT01273129n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Overnight TI in TLE NCT07434986NA1 site📍 Durham Duke University · Tests: Non-invasive Temporal Interference (TI) Stimulation Targeting Bilateral Hippocampi Retraining and Control Therapy (ReACT)- Adults NCT06570954NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders NCT07847918Phase 21 site📍 San Diego Scripps Translational Science Institute · Tests: Glycerol Phenylbutyrate Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight NCT01238250n/a2 sites📍 Boston📍 Lewisburg Simons Searchlight A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy NCT07227857Phase 1, Phase 215 sites📍 Orange📍 Boston📍 Rochester Institut de Recherches Internationales Servier · Tests: S230815- Starting dose A, S230815- Dose B, S230815- Dose C, S230815- Dose D
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy